Professional Medical Expertise Company (TADAWUL:9574)
Saudi Arabia · Delayed Price · Currency is SAR 84.50
+2.50 (3.05%)
Sep 24, 2026, 2:59 PM AST
TADAWUL:9574 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 296 | 340 | 315 | 250 | - | - | |
Market Cap Growth | -4.52% | 7.90% | 25.73% | - | - | - |
Enterprise Value | 392 | 443 | 409 | 321 | - | - |
Last Close Price | 84.50 | 97.00 | 88.85 | 67.81 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.73 | 8.14 | 11.38 | 10.07 | - | - |
PS Ratio | 0.67 | 0.81 | 1.00 | 1.00 | - | - |
PB Ratio | 1.69 | 2.26 | 2.78 | 2.58 | - | - |
P/TBV Ratio | 1.72 | 2.26 | 2.78 | 2.58 | - | - |
P/OCF Ratio | 9.11 | 474.63 | - | 42.56 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.89 | 1.06 | 1.31 | 1.29 | - | - |
EV/EBITDA Ratio | 5.36 | 6.71 | 9.24 | 8.68 | - | - |
EV/EBIT Ratio | 6.22 | 7.42 | 10.38 | 9.72 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.61 | 0.84 | 0.83 | 0.66 | 0.80 | 0.95 |
Debt / EBITDA Ratio | 1.44 | 1.84 | 2.04 | 1.67 | 2.02 | 1.41 |
Debt / FCF Ratio | 7.71 | - | - | - | - | 2.14 |
Net Debt / Equity Ratio | 0.55 | 0.81 | 0.79 | 0.65 | 0.73 | 0.51 |
Net Debt / EBITDA Ratio | 1.36 | 1.85 | 2.01 | 1.71 | 1.90 | 0.77 |
Net Debt / FCF Ratio | 7.01 | -5.18 | -10.52 | -20.46 | -5.10 | 1.14 |
Asset Turnover | 1.04 | 1.13 | 1.04 | 1.05 | 0.97 | 0.94 |
Inventory Turnover | 1.64 | 1.57 | 1.34 | 1.48 | 1.52 | 1.55 |
Quick Ratio | 0.96 | 0.90 | 0.73 | 0.81 | 0.90 | 0.90 |
Current Ratio | 1.60 | 1.55 | 1.57 | 1.53 | 1.59 | 1.33 |
Return on Equity (ROE) | 28.67% | 31.66% | 26.28% | 29.16% | 33.67% | 64.79% |
Return on Assets (ROA) | 9.26% | 10.04% | 8.19% | 8.64% | 8.89% | 10.91% |
Return on Invested Capital (ROIC) | 21.31% | 23.02% | 19.99% | 21.03% | 25.34% | 40.15% |
Return on Capital Employed (ROCE) | 32.70% | 35.60% | 31.00% | 30.60% | 31.80% | 53.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 14.85% | 12.29% | 8.79% | 9.93% | - | - |
FCF Yield | 4.63% | -6.93% | -2.69% | -1.24% | - | - |
Dividend Yield | 1.18% | - | 1.13% | - | - | - |
Payout Ratio | 7.97% | 8.39% | 36.08% | - | 84.14% | 14.06% |
Buyback Yield / Dilution | - | - | - | -56.73% | -189.51% | - |
Total Shareholder Return | 1.18% | - | 1.13% | -56.73% | -189.51% | - |